Table 2 Impact of Medicare Part D on antidementia prescriptions filled annually
From: The impact of Medicare prescription drug coverage on the use of antidementia drugs
Pharmacy benefit group | Proportion with any use pre–Part D | Proportion with any use post–Part D | Adjusted odds ratio* of pre–Part D vs. post–Part D drug use | Comparison of the adjusted odds ratio* of the no coverage, $150 cap, and $350 cap groups with that of the no cap group | ||
|---|---|---|---|---|---|---|
AOR (95% CI) | PValue | AOR (95% CI) | PValue | |||
No coverage group | 0.02 (0.14) | 0.04 (0.20) | 2.19 (1.85-2.59) | <0.0001 | 1.38 (1.14-1.66) | 0.0008 |
$150 cap group | 0.03 (0.16) | 0.05 (0.21) | 1.80 (1.52-2.13) | <0.0001 | 1.13 (0.94-1.37) | 0.1939 |
$350 cap group | 0.03 (0.16) | 0.05 (0.21) | 1.71 (1.61-1.82) | <0.0001 | 1.07 (0.97-1.19) | 0.1626 |
No cap group | 0.03 (0.17) | 0.05 (0.21) | 1.59 (1.47-1.72) | <0.0001 | [Reference] | |